Table 1 Changes in the number of antipsychotics/antidepressants for subjects with schizophrenia/major depression disorder
| Â | Â | antipsychotics for subjects with schizophrenia*1 | antidepressants for subjects with MDD*1 | ||
|---|---|---|---|---|---|
discharge | discharge | ||||
monotherapy | polypharmacy | monotherapy | polypharmacy | ||
admission | monotherapy | 866 (41.3%) | 260 (12.4%) | 508 (62.4%) | 78 (9.6%) |
polypharmacy | 254 (12.1%) | 718 (34.2%) | 92 (11.3%) | 136 (16.7%) | |